Ratator Cuff Injury
Conditions
Interventions
Group A:Therapeutic regimen: Injection into the affected shoulder joint cavity combined with periarticular nerve block (1% lidocaine 60mg + mecobalamin 0.5mg + compound betamethasone 5mg + normal sali
Group B:Therapeutic regimen: Injection into the affected shoulder joint cavity combined with periarticular nerve block (1% lidocaine 60mg + mecobalamin 0.5mg + compound betamethasone 5mg+ normal salin
Sponsors
Affiliated Hospital of Xuzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients meeting the diagnostic criteria for rotator cuff injury, with persistent pain in the affected shoulder for >3 months, Zlatkin classification type I-II, aged 18-75 years, Numeric Rating Scale (NRS) score >=4, BMI 18-24, and serum 25-hydroxyvitamin D [25(OH)D] level <75 nmol/L (30 ng/mL).
Exclusion criteria
Exclusion criteria: 1. Presence of other significant shoulder pathologies (e.g., fractures, rheumatic diseases); 2. History of neck or shoulder surgery; 3. Patients currently taking vitamin D supplements; 4. Conditions such as hyperphosphatemia with renal rickets, hypervitaminosis D, hypothyroidism/hyperthyroidism; 5. Patients with primary or secondary hyperparathyroidism;6.Renal insufficiency or hypercalcemia; 7. Pregnant or lactating women; 8. Participation in other clinical trials currently or within the past 12 weeks; 9. Inability to comprehend study scales/questionnaires or refusal to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| shoulder function;sleep quality;inflammatory factor levels;Depression Index;anxiety index;the level of Vitamin D; | — |
Countries
China
Contacts
Public ContactYin Qin
Department of Pain,Affiliated Hospital of Xuzhou Medical University
Outcome results
None listed